1143PResponses and durability of clinical benefit in pancreatic ductal adenocarcinoma (PDAC) patients treated with pegilodecakin (AM0010) in combination with 5-FU/LV and oxaliplatin (FOLFOX).
Saved in:
| Title: | 1143PResponses and durability of clinical benefit in pancreatic ductal adenocarcinoma (PDAC) patients treated with pegilodecakin (AM0010) in combination with 5-FU/LV and oxaliplatin (FOLFOX). |
|---|---|
| Authors: | Hecht, J R1 (AUTHOR), Naing, A2 (AUTHOR), Falchook, G S3 (AUTHOR), Patel, M R4 (AUTHOR), Aljumaily, R5 (AUTHOR), Wong, D J6 (AUTHOR), Autio, K A7 (AUTHOR), Wainberg, Z A6 (AUTHOR), Javle, M8 (AUTHOR), Bendell, J9 (AUTHOR) |
| Source: | Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p. 1 Chart. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 133286773 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 1143PResponses and durability of clinical benefit in pancreatic ductal adenocarcinoma (PDAC) patients treated with pegilodecakin (AM0010) in combination with 5-FU/LV and oxaliplatin (FOLFOX). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Hecht%2C+J+R%22">Hecht, J R</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Naing%2C+A%22">Naing, A</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Falchook%2C+G+S%22">Falchook, G S</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Patel%2C+M+R%22">Patel, M R</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Aljumaily%2C+R%22">Aljumaily, R</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wong%2C+D+J%22">Wong, D J</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Autio%2C+K+A%22">Autio, K A</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wainberg%2C+Z+A%22">Wainberg, Z A</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Javle%2C+M%22">Javle, M</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bendell%2C+J%22">Bendell, J</searchLink><relatesTo>9</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p. 1 Chart. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=133286773 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/annonc/mdy288.016 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: N.PAG Titles: – TitleFull: 1143PResponses and durability of clinical benefit in pancreatic ductal adenocarcinoma (PDAC) patients treated with pegilodecakin (AM0010) in combination with 5-FU/LV and oxaliplatin (FOLFOX). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hecht, J R – PersonEntity: Name: NameFull: Naing, A – PersonEntity: Name: NameFull: Falchook, G S – PersonEntity: Name: NameFull: Patel, M R – PersonEntity: Name: NameFull: Aljumaily, R – PersonEntity: Name: NameFull: Wong, D J – PersonEntity: Name: NameFull: Autio, K A – PersonEntity: Name: NameFull: Wainberg, Z A – PersonEntity: Name: NameFull: Javle, M – PersonEntity: Name: NameFull: Bendell, J IsPartOfRelationships: – BibEntity: Dates: – D: 04 M: 10 Text: 2018 Supplement Type: published Y: 2018 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 29 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
